Table 2.
Characteristics of IBD Patients Who Developed Cancer | |
---|---|
Number (%) (Range) | |
Age at cancer diagnosis | 52.9 (19–78) |
Sex | Male 39 (55.7) |
Female 31 (44.3) | |
IBD type | UC 32 (45.7) |
CD 38 (54.3) | |
Drug exposure | Aminosalicylates 62% |
Antimetabolite 40% | |
Biologics 43% | |
Family * history of cancer | 31% |
Smoker (past or current) | 64% |
IBD: inflammatory bowel disease; UC: ulcerative colitis; CD: Crohn’s disease. * Family defined as first-degree relatives.